An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels

被引：23
|
作者：
Roesner, Thies [1 ,2 ]
Derer, Stefanie [1 ,2 ]
Kellner, Christian [1 ,2 ]
Dechant, Michael [2 ,3 ]
Lohse, Stefan [1 ,2 ]
Vidarsson, Gestur [4 ,5 ]
Peipp, Matthias [1 ,2 ]
Valerius, Thomas [1 ,2 ]
机构：
[1] Univ Kiel, Dept Med 2, Div Stem Cell Transplantat & Immunotherapy, Kiel, Germany
[2] Univ Hosp Schleswig Holstein, Kiel, Germany
[3] Univ Kiel, Dept Med Nephrol & Hypertens 4, Kiel, Germany
[4] Sanquin Res, Dept Expt Immunohaematol, Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2013年 / 161卷 / 02期
关键词：
rituximab; IgG3; complement-dependent cytotoxicity; chronic lymphocytic leukaemia; MONOCLONAL-ANTIBODIES; LYMPHOMA;
D O I：
10.1111/bjh.12209
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：282 / 286
页数：5
相关论文
共 32 条
  • [1] An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumor cells with low CD20 expression levels
    Derer, Stefanie
    Roessner, Thies
    Dechant, Michael
    Lohse, Stefan
    Kellner, Christian
    Peipp, Matthias
    Valerius, Thomas
    IMMUNOBIOLOGY, 2012, 217 (11) : 1138 - 1138
  • [2] An IgG3 isotype switch variant of cetuximab triggers enhanced complement-mediated cytotoxicity against tumor cells with low CD55 expression levels
    Roesner, T.
    Lohse, S.
    Peipp, M.
    Valerius, T.
    Derer, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 113 - 113
  • [3] Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9
    Taylor, Ronald P.
    Lindorfer, Margaret A.
    Cook, Erika M.
    Beurskens, Frank J.
    Schuurman, Janine
    Parren, Paul W. H. I.
    Zent, Clive S.
    VanDerMeid, Karl R.
    Burack, Richard
    Mizuno, Masashi
    Morgan, B. Paul
    CLINICAL IMMUNOLOGY, 2017, 181 : 24 - 28
  • [4] Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation
    Hayashi, Kazumi
    Nagasaki, Eijiro
    Kan, Shin
    Ito, Masaki
    Kamata, Yuko
    Homma, Sadamu
    Aiba, Keisuke
    CANCER SCIENCE, 2016, 107 (05): : 682 - 689
  • [5] Low pH impairs complement-dependent cytotoxicity against IgG-coated target cells
    Dantas, Ezequiel
    Erra Diaz, Fernando
    Gerber, Pehuen Pereyra
    Merlotti, Antonela
    Varese, Augusto
    Ostrowski, Matias
    Sabatte, Juan
    Geffner, Jorge
    ONCOTARGET, 2016, 7 (45) : 74203 - 74216
  • [6] BORTEZOMIB MODULATES SURFACE CD20 IN B-CELL MALIGNANCIES AND AFFECTS RITUXIMAB-MEDIATED COMPLEMENT-DEPENDENT CYTOTOXICITY
    Winiarska, M.
    Bil, J.
    Bojarczuk, K.
    Nowis, D.
    Golab, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 171 - 172
  • [7] Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity
    Bil, Jacek
    Winiarska, Magdalena
    Nowis, Dominika
    Bojarczuk, Kamil
    Dabrowska-Iwanicka, Anna
    Basak, Grzegorz W.
    Sulek, Kazimierz
    Jakobisiak, Marek
    Golab, Jakub
    BLOOD, 2010, 115 (18) : 3745 - 3755
  • [8] Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity
    Lohse, Stefan
    Loew, Sebastian
    Kretschmer, Anna
    Jansen, J. H. Marco
    Meyer, Saskia
    ten Broeke, Toine
    Roesner, Thies
    Dechant, Michael
    Derer, Stefanie
    Klausz, Katja
    Kellner, Christian
    Schwanbeck, Ralf
    French, Ruth R.
    Tipton, Thomas R. W.
    Cragg, Mark S.
    Schewe, Denis M.
    Peipp, Matthias
    Leusen, Jeanette H. W.
    Valerius, Thomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (03) : 413 - 417
  • [9] Lack of lipid raft domain reorganization following ligation of CD20 is associated with resistance to rituximab-induced complement-dependent cytotoxicity
    Olejniczak, SH
    Hernandez-Ilizaliturri, FJ
    Clements, JL
    Czuczman, MS
    BLOOD, 2005, 106 (11) : 284B - 284B
  • [10] Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity
    Winiarska, Magdalena
    Nowis, Dominika
    Bil, Jacek
    Glodkowska-Mrowka, Eliza
    Muchowicz, Angelika
    Wanczyk, Malgorzata
    Bojarczuk, Kamil
    Dwojak, Michal
    Firczuk, Malgorzata
    Wilczek, Ewa
    Wachowska, Malgorzata
    Roszczenko, Katarzyna
    Miaczynska, Marta
    Chlebowska, Justyna
    Basak, Grzegorz Wladyslaw
    Golab, Jakub
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (38) : 31983 - 31993
1234